Deals Of The Week: Tire-Kicking Season Continues Full-Swing

 
• By Lisa LaMotta, Jessica Merrill, Stacy Lawrence, Paul Bonanos, and David Filmore

As Roche’s reported interest in buying rare-disease specialist Alexion faded, new suitors popped up for oncology specialist Onyx. Plus news on deals between Spectrum and Talon, Pfizer and Sequella, Medtronic and Amgen, and a new direction for Rexahn.

More from Archive

More from Pink Sheet